It’s officially day one of #BIO2018 for Boston, the industry, and RareMoon. Co-founders, Chris and Sabrina, will be taking on #BIO2018 together this year to divide, conquer, and make the best of the week.
This year has already been a fantastic year for RareMoon and our growth both as a company and in the intimate support we’ve provided to global biotech & pharma companies developing orphan medicines. A few of those highlights include:
- Navigating the challenges (and flexibilities) in developing gene therapies for rare and ultra-rare diseases,
- Designing a Breakthrough Therapy-worthy oncology clinical trial,
- Taking advantage of expedited programs,
- What “orphan drug exclusivity” means in the context of combination therapies,
- And more.
This week, we’re attending #BIO2018 to discuss these and other topics with our current and future Clients. Our team has done a fantastic job to ready RareMoon for this conference, and we are looking forward to an action-packed week, talking business and regulatory strategy, and getting updates from leading experts in the pharmaceutical industry.
Here’s a look at RareMoon’s week.
This week we’ll lead 41 One-on-One BioPartnering meetings with global biotech companies developing orphan therapies to talk regulatory incentives, expedited programs and more.
We’ll attend:
Super Sessions
A “Fireside chat with Dr. Scott Gottlieb,” Commissioner of the US FDA to hear about what new modernization plans he has for the FDA this year and beyond.
“Delivering on the Promise of Gene Therapies. Looking forward to hearing what these experts what it takes to bring these new types of medicines to patients.
Genome Editing Track
Advancements and Regulatory Framework in Human Genome Editing. What will this panel of experts have to share about navigating the regulatory requirements?
Oncology Track
A recap of “What was hot at ASCO” this year. Aside from #orthwestBio what else did we miss?
Orphan Drugs Track
We’ll hear experts talk about global newborn screening and the unique challenges of mitochondrial diseases.
Plus, a sponsored Tuesday morning Yoga class, Women in Bio Meet-up, BIO Patient Advocacy Reception and a Happy Hour! Phew.
If you’re looking to have a discussion with us this week or in the coming weeks, find us through the partnering forum or email us [email protected]. We’re excited to share what we will learn, lead or how we can support your newest regulatory mission.
